Life after a ventricular arrhythmia.

BACKGROUND There are few data from community-based evaluations of outcomes after a life-threatening ventricular arrhythmia (LTVA). We evaluated patients' quality of life (QOL) and medical costs after hospitalization and treatment for their first episode of an LTVA. METHODS We prospectively evaluated QOL by use of the Duke Activity Status Index (DASI), Medical Outcomes Study SF-36 mental health and vitality scales, the Cardiac Arrhythmia Suppression Trial (CAST) symptom scale, and resource use in patients discharged after a first episode of an LTVA in a managed care population of 2.4 million members. RESULTS We enrolled 264 subjects with new cases of LTVA. Although functional status initially decreased compared with self-reports of pre-event functional status, both functional status and symptom levels improved significantly during the study period. These improvements were greater in patients receiving an implantable cardioverter defibrillator (ICD) than in patients receiving amiodarone. Ratings of mental health and vitality were not significantly different between the treatment groups and did not change significantly during follow-up. The total 2-year medical costs were higher for patients receiving an ICD than for patients receiving amiodarone, despite lower costs during the follow-up period for the patients receiving an ICD. CONCLUSIONS New onset of an LTVA has a substantial negative initial impact on QOL. With therapy, most patients have improvements in their QOL and symptom level, possibly more so after treatment with an ICD. The costs of treating these patients are very high.

[1]  R. Cappato,et al.  Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH). , 2000, Circulation.

[2]  M Gent,et al.  Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. , 2000, Circulation.

[3]  K. Lee,et al.  A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. , 1999, The New England journal of medicine.

[4]  J. Windle,et al.  Quality‐of‐Life Six Months After CABG Surgery in Patients Randomized to ICD Versus No ICD Therapy: Findings from the CABG Patch Trial , 1999, Pacing and clinical electrophysiology : PACE.

[5]  N. Black,et al.  Interpreting the evidence: choosing between randomised and non-randomised studies , 1999, BMJ.

[6]  D. Carroll,et al.  Changes in health status and quality of life and the impact of uncertainty in patients who survive life-threatening arrhythmias. , 1999, Heart & lung : the journal of critical care.

[7]  P. Podrid.  Redefining the role of antiarrhythmic drugs. , 1999, The New England journal of medicine.

[8]  S. Feldstein,et al.  Health‐Related Quality‐of‐Life Assessment of Patients with Life‐Threatening Ventricular Arrhythmias , 1999, Pacing and clinical electrophysiology : PACE.

[9]  E. Prystowsky,et al.  Management of ventricular arrhythmias: detection, drugs, and devices. , 1999, JAMA.

[10]  D. Connelly,et al.  Implantable defibrillators for life threatening ventricular arrhythmias , 1998, BMJ.

[11]  A I Mushlin,et al.  The cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Multicenter Automatic Defibrillator Implantation Trial. , 1998, Circulation.

[12]  J. Bourke,et al.  Florid psychopathology in patients receiving shocks from implanted cardioverter-defibrillators , 1997, Heart.

[13]  M. Keller,et al.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.

[14]  Bigger Jt,et al.  Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery , 1997 .

[15]  A. Castellanos,et al.  Clinical trials of implantable defibrillators. , 1997, The New England journal of medicine.

[16]  M. Hegel,et al.  Anxiety and Depression in Patients Receiving Implanted Cardioverter-Defibrillators: A Longitudinal Investigation , 1997, International journal of psychiatry in medicine.

[17]  D. Mark,et al.  Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. , 1997, The New England journal of medicine.

[18]  A. Moss,et al.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. , 1996, The New England journal of medicine.

[19]  N. Black.  Why we need observational studies to evaluate the effectiveness of health care , 1996, BMJ.

[20]  D. Simonson,et al.  Assessment of quality-of-life outcomes. , 1996, The New England journal of medicine.

[21]  J. Windle,et al.  The quality of life of patients with life-threatening arrhythmias. , 1995, Archives of internal medicine.

[22]  H. Crijns,et al.  Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors. , 1995, Circulation.

[23]  D. Roden.  Risks and benefits of antiarrhythmic therapy. , 1994, The New England journal of medicine.

[24]  G. Naccarelli,et al.  Predicting and preventing sudden death from cardiac causes. , 1994, Circulation.

[25]  R. Myerburg,et al.  Sudden Cardiac Death: Epidemiology, Transient Risk, and Intervention Assessment , 1993, Annals of Internal Medicine.

[26]  Y. Pawitan,et al.  Methods for assessing quality of life in the Cardiac Arrhythmia Suppression Trial (CAST) , 1992, Quality of Life Research.

[27]  M A Hlatky,et al.  A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). , 1989, The American journal of cardiology.

[28]  A. Stewart,et al.  The MOS short-form general health survey. Reliability and validity in a patient population. , 1988, Medical care.

[29]  S. Zeger,et al.  Longitudinal data analysis using generalized linear models , 1986 .

[30]  K Y Liang,et al.  Longitudinal data analysis for discrete and continuous outcomes. , 1986, Biometrics.

[31]  F. Jones,et al.  International Classification of Diseases , 1978 .

[32]  G. Sanders,et al.  Cost-Effectiveness of Implantable Cardioverter Defibrillators Relative to Amiodarone for Prevention of Sudden Cardiac Death , 1997, Annals of Internal Medicine.

[33]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.